Loading...
Market
Primary Application Area for PacBio's SPRQ Chemistry in 2025?
2
Resolution / Starting Odds
Clinical diagnostics • 25%
Agricultural genomics • 25%
Pharmaceutical research • 25%
Consumer genomics • 25%
Industry reports and announcements by PacBio
Story
PacBio Unveils SPRQ Chemistry for Revio, Cutting Genome Sequencing Costs to $500
Oct 29, 2024, 04:41 PM
Pacific Biosciences (PacBio) has announced a significant advancement in its sequencing technology with the introduction of SPRQ chemistry for the Revio Sequencing Systems. This new long-read sequencing chemistry is expected to reduce the cost of sequencing a human genome to less than $500, which represents a 50% reduction in sequencing costs. The improvements are anticipated to increase the system's output and efficiency, marking a major milestone for the company and the genomics industry. This development is seen as an 'inflection point' for PacBio, potentially transforming the economics of genome sequencing. The announcement was made at ASHG24, and its impact on Kinnex will be discussed separately.
View original story
Similar markets
Human gene editing • 25%
Animal models • 25%
Plant genomics • 25%
Microbial engineering • 25%
Cancer Research • 25%
Neurological Disorders • 25%
Genetic Disorders • 25%
Other • 25%
Diagnostic Tool • 25%
Research Kit • 25%
Therapeutic Development Tool • 25%
Other • 25%
Respiratory infections • 25%
Bloodstream infections • 25%
Gastrointestinal infections • 25%
Other • 25%
Yes • 50%
No • 50%
Drug Development • 25%
Disease Diagnosis • 25%
Biosensor Technology • 25%
Other • 25%
Illumina • 25%
Thermo Fisher Scientific • 25%
Bio-Rad Laboratories • 25%
Other • 25%
Cryptography • 25%
Material Science • 25%
Artificial Intelligence • 25%
Other • 25%
Drug discovery • 25%
Agricultural biotechnology • 25%
Industrial biotechnology • 25%
Other • 25%